Swiss drugmaker Novartis is betting on heart drug prospect inclisiran in a $9.7 billion takeover of The Medicines Co as it challenges cardiovascular medicines from Amgen Inc , Sanofi and Regeneron Pharmaceuticals .
Roche expects its risdiplam medicine for spinal muscular atrophy (SMA) to get U.S. approval by May, the Swiss drugmaker said on Monday, as it takes on Novartis and Biogen in the lucrative rare disease area. The U.S. Food and Drug Administration granted priority review for risdiplam, an oral medicine for those with the potentially deadly muscle-wasting disorder. Roche, whose drug is seen as a rival for Biogen’s Spinraza and Novartis’s Zolgensma gene therapy, said the FDA is due to decide by May 24. …read more […]
European shares rose for the second straight session on Monday following reports that Washington and Beijing were nearing a trade agreement, while LVMH gained after signing a deal to buy U.S. jewellery chain Tiffany. A Chinese state-backed tabloid said on Monday China and the United States were “very close” to an initial trade agreement, adding to optimism from Friday, when the presidents of both the countries reiterated their desire for a deal. The pan-European STOXX 600 index was up 0.6% at 0802 GMT, led by trade-sensitive miners. …read more […]
Louis Vuitton owner LVMH has agreed to buy U.S. jeweler Tiffany for $16.2 billion in the luxury goods maker’s biggest acquisition to date.
(Bloomberg) — Istanbul is working on a plan to sell Eurobonds to finance projects after state lenders “shut the doors” on the city’s opposition-run local government, according to Mayor Ekrem Imamoglu.“It’s sad that the state lenders remain distant to us since we came into office,” Imamoglu told reporters on Sunday. “I don’t know what their motives are. However, I have no doubt that we will find funding from Europe.”The new mayor’s remarks highlight the difficulties he faces running the nation’s largest city after wresting control from Presidetn Recep Tayyip Erdogan’s ruling AK Party. Imamoglu was in London earlier this month …read more […]
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is… …read more […]
Today, we’ll introduce the concept of the P/E ratio for those who are learning about investing. We’ll show how you can… …read more […]
China’s foreign ministry said on Monday it hopes the United States will work with Beijing on a basis of equality and mutual respect on the ongoing bilateral trade negotiations.
LVMH has agreed a $16.2 billion deal to buy U.S. jeweler Tiffany, Louis Vuitton’s parent firm confirmed on Monday, in the luxury good maker’s biggest purchase to date.
LVMH has agreed a $16.2 billion deal to buy U.S. jeweller Tiffany, Louis Vuitton’s parent firm confirmed on Monday, in the luxury good maker’s biggest purchase to date. The deal will boost LVMH’s smallest business, the jeweller and watch division, home to Bulgari and Tag Heuer. “The acquisition of Tiffany will strengthen LVMH’s position in jewellery and further increase its presence in the United States,” LVMH and Tiffany said in a joint statement. …read more […]
(Bloomberg) — Novartis AG agreed to buy Medicines Co. for about $6.8 billion, snapping up a promising cholesterol drug and adding to a string of recent acquisitions for Chief Executive Officer Vas Narasimhan.Medicines Co. shareholders will get $85 a share, Basel, Switzerland-based Novartis said in a statement on Sunday. That’s a 45% premium to the closing price on Nov. 18, before Bloomberg reported the two companies were in talks. The transaction value reaches $9.7 billion on a fully diluted basis that includes outstanding stock options and convertible debt, Novartis said.The deal brings an experimental cholesterol treatment, inclisiran, into a stable …read more […]
Britain’s Just Eat advised shareholders not to accept a 710 pence-a-share cash offer from Prosus , saying it was inferior to its agreed deal with Takeaway.com to create the largest food delivery player outside China.
(Bloomberg) — LVMH agreed to buy Tiffany & Co. for more than $16 billion in the largest luxury-goods deal ever, raising the French conglomerate’s profile in jewelry and giving it access to a broader swath of American shoppers.The owner of the Louis Vuitton brand agreed to pay $135 a share for the U.S. jeweler, according to a statement Monday. That values Tiffany 37% above the closing price before Bloomberg reported an initial $120-a-share approach Oct. 26. Boards of both companies approved the proposal on Sunday.LVMH Chairman Bernard Arnault is challenging Cartier owner Richemont for dominance in the global jewelry business. …read more […]
French luxury goods group LVMH said on Monday it has reached a definitive agreement to buy U.S. jewelry chain Tiffany & Co for $135 per share in an all-cash offer, in a $16.2 billion deal.
LVMH has agreed a $16.2 billion deal to buy U.S. jeweler Tiffany, Louis Vuitton’s parent firm confirmed on Monday, in the luxury good maker’s biggest purchase to date. The deal will boost LVMH’s smallest business, the jeweler and watch division, home to Bulgari and Tag Heuer. Fashion and accessories brands including Christian Dior generate the bulk of the earnings at the conglomerate, which is run by France’s richest man, Bernard Arnault. …read more […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
